SEC Form 4 · accession 0000899243-18-018319

· DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 25, 2018

Accepted (ET)

Jun 27, 2018 · 4:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001690585

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jun 25, 2018	C	3,339,137	—	A	3,339,137	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F1,F2	—	Jun 25, 2018	C	133,400	D	—	—	Common Stock	51,626	0	I
Series B Preferred Stock^F1,F2	—	Jun 25, 2018	C	8,494,864	D	—	—	Common Stock	3,287,511	0	I

F1The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date.
F2The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P. Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose.